Rep. Brian Fitzpatrick (R-PA) Will Receive Charlie Devlin Award for Excellence at Upcoming TCA Fall
TCA has announced that this year's recipient of the Charlie Devlin Award for Excellence will be Representative Brian Fitzpatrick (R-PA),...
TCA has announced that this year's recipient of the Charlie Devlin Award for Excellence will be Representative Brian Fitzpatrick (R-PA),...
CDC [30-Jun] | The CDC recently released new prevention and surveillance resources, including a report on overdose deaths from fentanyl...
SAMHSA [13-Jun] | Recently, SAMHSA released a new data report indicating that lesbian, gay, and bisexual adults are more likely than...
SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine...
SUD Treatment for Racial/Ethic Minority Populations at High Risk for HIV/AIDS (Due 5/22) Promoting the Integration of Primary and...
DEA [3/22] | In a public safety alert, the DEA said it observed a sharp increase in the trafficking of fentanyl mixed with xylazine, a...
Intl Journal of Drug Policy| A recent study explored if naloxone expansion may inadvertently promote high-risk substance use behaviors...
JAMA [3/28] | More than 7% of urine samples collected in a recent cross-sectional study [...] showed evidence of buprenorphine...
JAMA (3/03) | A new study reports that high-dose buprenorphine administered in the emergency department for patients in withdrawal is...
U.S. House (3/09) | U.S. Representatives Joe Neguse (D-CO), Madeleine Dean (D-PA), Darrell Issa (R-CA), and Ken Calvert (R-CA) recently...
U.S. Senate [3/28] | Several senators are introducing the Combating Illicit Xylazine Act, bipartisan, bicameral legislation to crack down...
Improving Access to Overdose Treatment (Due 3/24) Residential Treatment for Pregnant and Postpartum Women (Due 3/27) SUD Treatment for...